Navigation Links
Plant microbe shares features with drug-resistant pathogen
Date:6/16/2009

UPTON, NY -- An international team of scientists has discovered extensive similarities between a strain of bacteria commonly associated with plants and one increasingly linked to opportunistic infections in hospital patients. The findings suggest caution in the use of the plant-associated strain for a range of biotech applications. The genetic analysis was conducted in part at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory, and will be published in the July 2009 issue of Nature Reviews Microbiology, now available online.

The research team - which included scientists from Ireland, Austria, and the United Kingdom as well as the U.S. - was investigating the versatility and adaptability of a group of bacteria known as Stenotrophomonas. These bacteria have great metabolic versatility, allowing them to thrive in very diverse environments.

The scientists were particularly interested in comparing two strains of S. maltophilia whose genomes were recently decoded to see why these strains - one isolated as an opportunistic pathogen from a clinical setting (strain K279a), and the other from the roots of poplar trees (strain R551-3) - were so well-suited to their very different environments. Such comparisons are made possible by the high throughput and cost-effective DNA sequencing capacity developed by DOE's Joint Genome Institute, as well as the Sanger Institute, to help elucidate the role of microorganisms in health, energy, and environmental processes.

"Surprisingly, we observed very few differences between the opportunistic pathogen and the common plant bacterium," said Brookhaven Lab microbiologist Daniel (Niels) van der Lelie, an expert on soil- and plant-associated microbes, whose team provided the data on the plant-dwelling strain.

For one thing, the scientists found genes that make the bacteria resistant to a wide range of antibiotics in both strains. "This suggests that antibiotic resistance is part of the species' core genome, and not a trait acquired in the hospital," van der Lelie said. Multi-drug antibiotic-resistance is one key feature that allows some bacteria to cause deadly infections in hospital patients whose immune systems are often compromised.

The scientists are also intrigued about similarities in the mechanisms the two strains use to colonize their respective environments. For example, both strains possess very similar mechanisms to produce glue-like substances, or biofilms, which allow them to adhere to plant roots, in one case, and medical devices such as ventilation tubes and intravenous catheters, in the other. Such devices are a common source of exposure to opportunistic pathogens for hospital patients.

Implications

"Soil microorganisms have long been a source and inspiration for the synthesis of antibiotics," van der Lelie said. "These finding will help us to better understand the potential of bacteria to produce or become resistant to antimicrobial compounds."

The findings may also reveal new targets for the development of drugs to interfere with microbes' ability to form sticky, infection-fostering biofilms, or point the way to closely related non-pathogenic strains that could be useful and benign for biotech applications.

On the other hand, these findings raise the question of whether plants in hospital settings may serve as a reservoir for opportunistic pathogens or antibiotic resistance genes. "This is something that should be looked at more closely by experts in infectious diseases," van der Lelie said.

The findings also suggest caution in using this particular strain of plant-dwelling bacteria for a range of biotech applications for which it and other plant-associated microbes have shown promise. These include: stimulating plant growth and protecting plants against pathogens; the breakdown of natural and man-made pollutants via bioremediation and phytoremediation; and the production of useful biomolecules such as drugs or industrial enzymes.

Based on the results of this study, van der Lelie's group has ruled out S. maltophilia for biotech applications designed to increase plant growth. "The work in our lab is presently concentrating on two other plant-growth promoting bacteria, Pseudomonas putida W619 and Enterobacter sp. 638, neither of which contain broad spectrum antibiotic resistance or virulence factors that would allow them to behave as opportunistic pathogens," he said. "We are certain about this after carefully analyzing the genome sequences of these strains."


'/>"/>

Contact: Karen McNulty Walsh
kmcnulty@bnl.gov
631-344-8350
DOE/Brookhaven National Laboratory
Source:Eurekalert

Related biology news :

1. Protein that triggers plant cell division revealed by researchers
2. Is this the beginning of the end of plant breeding?
3. REGiMMUNE presents enhanced efficacy data in preclinical transplantation models
4. NASA satellite detects red glow to map global ocean plant health
5. Scientists develop a new HIV microbicide -- and a way to mass produce it in plants
6. Understanding plants overactive immune system will help MU researchers build better crops
7. MSU discoveries upend traditional thinking about how plants make certain compounds
8. Plant Min protein sits tight and rescues E. coli
9. ISU researcher identifies genetic pathway responsible for much of plant growth
10. MIT’s implantable device offers continuous cancer monitoring
11. Bacteria create aquatic superbugs in waste treatment plants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ALAMEDA, Calif. , Dec. 8, 2016  Singulex, ... Single Molecule Counting technology, entered into a license and ... in serving science. The agreement provides Singulex access to ... Europe is used to diagnose ... the United States to aid in assessing ...
(Date:12/7/2016)... Israel , December 7, 2016 BioCatch ... the expansion of its patent portfolio, which grew to over 40 granted ... , , ... its recently filed patent entitled " System, Device, and Method ... technology that enables device makers to forego costly hardware components needed to ...
(Date:12/7/2016)... --  Veridium , a leader in biometrics-based authentication ... James Stickland . Stickland, a seasoned financial ... served in senior executive roles for HSBC, JPMorgan ... a pipeline of venture capital and accelerating innovation ... as managing director of U.K.-based fintech firm Red ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , December 8, 2016 ... für Molekulargenetik, erweitert seine Palette an anpassbaren SureSeq™ ... Custom FH Panels, das ein schnelles und kostengünstiges ... Das Panel bietet eine Erkennung von Einzel-Nukleotid-Variationen (Single ... mit einem einzigen kleinen Panel und ermöglicht eine ...
(Date:12/8/2016)... ... 08, 2016 , ... Microbial genomics leader, uBiome, joins Google, ... of just six company finalists in the Health & Medicine category. Over 1,000 ... as finalists in this year’s awards include Google, SpaceX, Oculus, and SolarCity. Individuals ...
(Date:12/8/2016)... N.J. , Dec. 8, 2016 ... augmentation remediation technologies and selected NewTechBio,s NT-MAX ... a microbial based beneficial bacteria, in conjunction with ... to correct deficiencies with National Pollutant Discharge Elimination ... 281-8H has experienced a steady history of elevated ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... that “in the setting of previously treated, advanced pancreatic cancer, liquid biopsies are ... optimal patient population and timing of blood sampling may improve the value of ...
Breaking Biology Technology: